| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
208,197,000
|
157,662,000
|
121,312,000
|
107,133,000
| | Cost of Revenue | 111,506,000 | 75,592,000 | 53,468,000 | 48,762,000 | | |
Gross Profit
|
96,691,000
|
82,070,000
|
67,844,000
|
58,371,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 139,892,000 | 100,137,000 | 74,204,000 | 67,458,000 | | | |
Operating Income or Loss
|
68,305,000
|
57,525,000
|
47,108,000
|
39,675,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 68,305,000 | 57,525,000 | 47,108,000 | 39,675,000 |
|
Interest Expense | (3,131,000) | (3,180,000) | (3,146,000) | (3,786,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 13,951,000 | 11,473,000 | 9,626,000 | 7,076,000 |
|
Minority Interest | (6,832,000) | (5,635,000) | (4,480,000) | (3,258,000) |
|
|
|
Net Income From Continuing Ops | 52,509,000 | 44,469,000 | 36,186,000 | 29,899,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
45,677,000
|
38,834,000
|
31,706,000
|
26,641,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|